Neurology Central

Pharmacogenetics in electroconvulsive therapy and adjunctive medications


Electroconvulsive therapy (ECT) has shown apparent efficacy in treatment of patients with depression and other mental illnesses who do not respond to psychotropic medications or need urgent control of their symptoms. Pharmacogenetics contributes to an individual’s sensitivity and response to a variety of drugs.

To view restricted content, please:

Leave A Comment